fda stance on compounded semaglutide is not the same as FDA-approved. The has documented dosing errors and hospitalizations linked to these products. Dr. Jen Ashton breaks down the risks. Always consult your physician before Semaglutide FDA Approval vs Compounded

However, the broad distribution of GLP-1 receptors across various tissues, such as the pancreas, lungs, kidneys, central nervous system, cardiovascular system, gastrointestinal tract, skin, and thyroid gland, has raised concerns about the potential impact of GLP-1 RAs on cancer development and progression [23]

Timing tells us everything

Body composition research protocol Researchers interested in body composition changes, specifically the ratio of fat loss to lean mass preservation, face a nuanced dosing consideration

Another person (unidentified) suggested that by decreasing inflammation around the capillaries, the GLP-1 agonists were increasing blood flows